Purpose Canadian Financial Income Fund Series ETF (TSE:BNC – Get Free Report) fell 0% during trading on Monday . The company traded as low as C$29.58 and last traded at C$29.63. 400 shares were traded during mid-day trading, a decline of 73% from the average session volume of 1,477 shares. The stock had previously closed at C$29.64.
Purpose Canadian Financial Income Fund Series ETF Stock Down 0.0 %
The company’s fifty day simple moving average is C$28.49 and its 200-day simple moving average is C$26.34.
Purpose Canadian Financial Income Fund Series ETF Company Profile
Telesta Therapeutics Inc is a human therapeutics company. The Company is a biotechnology company, which is focused on the licensing/acquisition and development of transformational therapeutics for the treatment of human diseases, such as cancer, immune diseases and targeted rare diseases. The Company focuses on developing drug candidate, Mycobacterium phlei cell wall-nucleic acid complex (MCNA) for the treatment of non-muscle invasive bladder cancer.
Featured Stories
- Five stocks we like better than Purpose Canadian Financial Income Fund Series ETF
- How to trade using analyst ratings
- How to Master Trading Discipline: Overcome Emotional Challenges
- What is an Earnings Surprise?
- Does China Investigation Change NVIDIA’s Outlook; Yes, No, Maybe?
- 3 Fintech Stocks With Good 2021 Prospects
- Is Marvell Technology Chipping Away at NVIDIA’s Market Lead?
Receive News & Ratings for Purpose Canadian Financial Income Fund Series ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Purpose Canadian Financial Income Fund Series ETF and related companies with MarketBeat.com's FREE daily email newsletter.
